CD28 and chronic kidney disease: The IVW method revealed that an increase of CD28 on CD39 + CD8 + T cell was associated with a lower risk of CKD (OR = 0.97; 95% CI = 0.96–0.99; p < 0.001, FDR = 0.006), which was supported by other MR methods.